δ9-THC-d9 (CRM)
(Synonyms: Δ9-Tetrahydrocannabinol-d9, Dronabinol-d9) 目录号 : GC49579A Certified Reference Material
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
δ9-THC-d9 (CRM) is intended for use as an internal standard for the quantification of δ9-THC-d9 by GC- or LC-MS. δ9-THC-d9 is categorized as a cannabinoid.1,2 It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3 δ9-THC-d9 is regulated as a Schedule I compound in the United States. δ9-THC-d9 (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
1.Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al.1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptorsBioorg. Med. Chem. Lett.16(20)5432-5435(2006) 2.Pertwee, R.G.Pharmacology of cannabinoid receptor ligandsCurr. Med. Chem.6(8)635-664(1999) 3.Grotenhermen, F.Pharmacokinetics and pharmacodynamics of cannabinoidsClin. Pharmacokinet.42(4)327-360(2003)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.0912 mL | 15.456 mL | 30.9119 mL |
5 mM | 0.6182 mL | 3.0912 mL | 6.1824 mL |
10 mM | 0.3091 mL | 1.5456 mL | 3.0912 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。